Finding a cure for sickle cell disease
Cure Sickle Cell
['FUNDING_OTHER'] · MEDICAL COLLEGE OF WISCONSIN · NIH-10912972
The Cure Sickle Cell Initiative is working with patients, families, and advocates to find a cure for sickle cell disease by exploring safe genetic therapies and teaming up with various organizations to speed up the development of new treatments that can improve lives.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | MEDICAL COLLEGE OF WISCONSIN (nih funded) |
| Locations | 1 site (MILWAUKEE, UNITED STATES) |
| Trial ID | NIH-10912972 on ClinicalTrials.gov |
What this research studies
The Cure Sickle Cell Initiative aims to engage the sickle cell disease community, including patients, families, and advocates, to collaborate on finding a cure. This initiative focuses on utilizing safe and reliable genetic therapies to improve the lives of individuals affected by sickle cell disease. By fostering partnerships between government agencies, biopharmaceutical companies, and researchers, the initiative seeks to accelerate the development of innovative treatments and technologies for sickle cell disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with sickle cell disease, including those with Hb SS disease.
Not a fit: Patients with other forms of anemia or those without a diagnosis of sickle cell disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to groundbreaking genetic therapies that significantly improve or even cure sickle cell disease.
How similar studies have performed: Previous research has shown promise in using genetic therapies for sickle cell disease, indicating a potential for success in this initiative.
Where this research is happening
MILWAUKEE, UNITED STATES
- MEDICAL COLLEGE OF WISCONSIN — MILWAUKEE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: EAPEN, MARY — MEDICAL COLLEGE OF WISCONSIN
- Study coordinator: EAPEN, MARY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Hb SS disease, HbSS disease, Hemoglobin S Disease, Hemoglobin sickle cell disease, Hemoglobin sickle cell disorder